This assignment presents a discussion around the central question: Should businesses be banned from selling harmful products to improve public health? The arguments are structured around premises concerning the impact of harmful products on population health and business efficiency, the need for quality control and ethical business practices, and the potential for companies to improve health-related goals. The assignment includes perspectives from three speakers, each offering a main conclusion, supporting premises, and opportunities to support or challenge the central argument. Speaker 1 emphasizes the importance of mechanical checks and customer support, while Speaker 2 advocates for banning companies that sell harmful products. Speaker 3 focuses on the negative impact of harmful selling on both the company's business profile and its overall goodwill. The assignment further highlights challenges such as new investments and rising business demands, providing a comprehensive overview of the complexities involved in the debate.
![[object Object]](/_next/static/media/star-bottom.7253800d.svg)
